{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:43:45Z","timestamp":1778193825857,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bioorg.2024.107853","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:36:36Z","timestamp":1728095796000},"page":"107853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of novel and potent sulfonamide derivatives as orally available drug for psoriasis"],"prefix":"10.1016","volume":"153","author":[{"given":"Liang","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Nuo","family":"Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Shang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Ru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107853_b0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2014.04.004","article-title":"Small-molecule ROR\u03b3t antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms","volume":"40","author":"Xiao","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2024.107853_b0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrrheum.2015.53","article-title":"The IL-23\u2212IL-17 axis in inflammatory arthritis","volume":"11","author":"Lubberts","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bioorg.2024.107853_b0015","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.4049\/jimmunol.1302190","article-title":"Pharmacologic inhibition of ROR\u03b3t regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo","volume":"192","author":"Skepner","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2024.107853_b0020","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor ROR\u03b3t directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2024.107853_b0025","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2024.107853_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13555-016-0102-0","article-title":"Ixekizumab for the treatment of psoriasis: a review of phase III traials","volume":"6","author":"Farahnik","year":"2016","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.bioorg.2024.107853_b0035","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1021\/jm401901d","article-title":"Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-\u03b3 (ROR\u03b3 or RORc)","volume":"57","author":"Fauber","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0040","doi-asserted-by":"crossref","first-page":"10976","DOI":"10.1021\/acs.jmedchem.8b00588","article-title":"Combating Autoimmune diseases with retinoic acid receptor related orphan receptor-\u03b3 (ROR\u03b3 or RORc) inhibitors: hits and misses","volume":"61","author":"Pandya","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2024.107853_b0050","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.aaa4282","article-title":"Impairment of immunity to candida and mycobacterium in humans with bi-allelic RORC mutations","volume":"349","author":"Okada","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2024.107853_b0055","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1021\/acs.jmedchem.8b00783","article-title":"Potent and orally bioavailable inverse agonists of ROR\u03b3t resulting from structure-based design","volume":"61","author":"Narjes","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0060","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1021\/acs.jmedchem.8b00061","volume":"61","author":"Kono","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acsmedchemlett.5b00253","article-title":"SAR exploration guided by LE and Fsp3: discovery of a selective and orally efficacious ROR\u03b3 inhibitor","volume":"7","author":"Hirata","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107853_b0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejmech.2019.01.082","article-title":"Discovery of N-indanyl benzamides as potent RORgt inverse agonists","volume":"167","author":"Tian","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0075","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1021\/acs.jmedchem.8b00529","article-title":"Optimizing a weakly binding fragment into a potent ROR\u03b3t inverse agonist with efficacy in an in vivo inflammation model","volume":"61","author":"Carcache","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0080","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1021\/acs.jmedchem.5b00597","volume":"58","author":"Fauber","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2016.1153066","article-title":"Retinoid-related orphan receptor gamma t (ROR\u03b3t) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742","volume":"26","author":"Gege","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107853_b0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/acsmedchemlett.5b00122","article-title":"Discovery of biaryl amides as potent, orally bioavailable, and CNS penetrant ROR\u03b3t inhibitors","volume":"6","author":"Wang","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107853_b0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/mol.109.060905","article-title":"The benzenesulfonamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-(trifluoromethyl)ethyl]phenyl] benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-\u03b1\/\u03b3 inverse agonist","volume":"77","author":"Kumar","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2024.107853_b0100","series-title":"The discovery of AZD0284, an inverse agonist of the nuclear receptor ROR\u03b3. Drug Design and Delivery Symposium","author":"Narjes","year":"2017"},{"issue":"18","key":"10.1016\/j.bioorg.2024.107853_b0105","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1021\/acs.jmedchem.1c01197","article-title":"AZD0284, a potent, selective, and orally bioavailable inverse agonist of retinoic acid receptor-related orphan receptor C2","volume":"64","author":"Narjes","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0110","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/bjd.16131","article-title":"A Phase I randomised controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque Test","volume":"178","author":"Kang","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioorg.2024.107853_b0115","unstructured":"Study of safety and efficacy of topical GSK2981278 ointment in plaque psoriasis. ClinicalTrials.Gov; U.S. National Insitutes of Health: Bethesda, MD, 2018; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02548052."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107853_b0120","doi-asserted-by":"crossref","first-page":"e0147979","DOI":"10.1371\/journal.pone.0147979","article-title":"Development of a Topical Treatment for Psoriasis Targeting ROR\u03b3: From Bench to Skin","volume":"11","author":"Smith","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2024.107853_b0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/13543776.2019.1655541","article-title":"Retinoic acid receptor-related orphan receptor gamma-t (ROR\u03b3t) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)","volume":"29","author":"Sun","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107853_b0130","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.bmcl.2018.03.041","article-title":"Sulfoximines as potent ROR\u03b3 inverse agonists","volume":"28","author":"Ouvry","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.bioorg.2024.107853_b0135","doi-asserted-by":"crossref","first-page":"16106","DOI":"10.1021\/acs.jmedchem.1c01436","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114065","article-title":"Discovery of 2H-chromone-4-one based sulfonamide derivatives as potent retinoic acid receptor-related orphan receptor \u03b3t inverse agonists","volume":"229","author":"Chen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107853_b0145","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/me.2009-0507","article-title":"Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma","volume":"24","author":"Jin","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.bioorg.2024.107853_b0150","doi-asserted-by":"crossref","unstructured":"James J.-W. Duan, Zhonghui Lu, Bin Jiang, Sylwia Stachura, Carolyn A. Weigelt, John S. Sack, Javed Khan, Max Ruzanov, Michael A. Galella, Dauh-Rurng Wu, Melissa Yarde, Ding-Ren Shen, David J. Shuster, Virna Borowski, Jenny H. Xie, Lisa Zhang, Sridhar Vanteru, Arun Kumar Gupta, Arvind Mathur, Qihong Zhao, William Foster, Luisa M. Salter-Cid, Percy H. Carter, and T. G. Murali Dhar. Structure-based discovery of phenyl (3-phenylpyrrolidin-3-yl) sulfones as selective, orally active ROR\u03b3t inverse agonists. ACS Medicinal Chemistry Letters,2019,10(3), 367-373.","DOI":"10.1021\/acsmedchemlett.9b00010"},{"key":"10.1016\/j.bioorg.2024.107853_b0155","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/cmdc.201700278","article-title":"Structural states of ROR\u03b3t: X-ray elucidation of molecular mechanisms and binding interactions for natural and synthetic compounds","volume":"12","author":"Kallen","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107853_b0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1517\/17460441003605098","article-title":"Lipophilicity in drug discovery","volume":"5","author":"Waring","year":"2010","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.bioorg.2024.107853_b0165","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nature Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2024.107853_b0170","unstructured":"Birault, A. V.; Campbell, J.; Harrison, S.; Le J. Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor. US Patent US9150508B2, 2015."},{"key":"10.1016\/j.bioorg.2024.107853_b0175","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2024.107853_b0180","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2012.318","article-title":"An alternative pathway of imiquimod-induced psoriasis-Like skin inflammation in the absence of interleukin-17 receptor A signaling","volume":"133","author":"K. E., Malki, Karbach, S. H., Huppert, J., Zayoud, M., Rei\u00dfig, S., Sch\u00fcler, R., Nikolaev, A., Karram, K., M\u00fcnzel, T., Kuhlmann, C. R. W., Luhmann, H. J., Stebut, E., W\u00f6rtge, S., Kurschus, F. C., Waisman, A.","year":"2013","journal-title":"J. Invest. Dermatol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824007582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T02:24:09Z","timestamp":1738203849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824007582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"alternative-id":["S0045206824007582"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107853","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel and potent sulfonamide derivatives as orally available drug for psoriasis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107853"}}